One‐year clinical results of the NANO registry: A multicenter, prospective all‐comers registry study in patients receiving implantation of a polymer‐free sirolimus‐eluting stent | Zendy

Liu Yi | Zendy; Zhang Yaojun | Zendy; Li Yue | Zendy; Qi Tianjun | Zendy; Pan Defeng | Zendy; Wang Haichang | Zendy; Liu Changhui | Zendy; Ma Dengfeng | Zendy; Fang Zhenfei | Zendy; Zhang Ruining | Zendy; Mou Fangjun | Zendy; Tao Ling | Zendy

Premium

One‐year clinical results of the NANO registry: A multicenter, prospective all‐comers registry study in patients receiving implantation of a polymer‐free sirolimus‐eluting stent

Author(s) -

Liu Yi,

Zhang Yaojun,

Li Yue,

Qi Tianjun,

Pan Defeng,

Wang Haichang,

Liu Changhui,

Ma Dengfeng,

Fang Zhenfei,

Zhang Ruining,

Mou Fangjun,

Tao Ling

Publication year - 2020

Publication title -

catheterization and cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.988

H-Index - 116

eISSN - 1522-726X

pISSN - 1522-1946

DOI - 10.1002/ccd.28734

Subject(s) - medicine , stent , myocardial infarction , target lesion , clinical endpoint , drug eluting stent , ejection fraction , coronary stent , cardiology , surgery , percutaneous coronary intervention , clinical trial , heart failure , restenosis

We aimed to evaluate the safety and efficacy of Nano+™ (Lepu Medical, Beijing, China) stent implantation in all-comer patients at the 1-year follow-up.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research